Stem cell researchers face down stem cell tourism
By Bryn Nelson,
Nature Reports Stem Cells
| 06. 05. 2008
In April, a paralysed man returning to Colorado from experimental stem cell therapy in India said he could feel the waistband of his pants for the first time in years. Like others before him, he couldn't say how many cells he had received or how his treatments had worked. Nor had his doctor published any details.
In the end, members of CareCure , an online forum for patients, caregivers and their advocates were left to parse through a tantalizing yet frustratingly incomplete anecdote once again.
"Not another one of 'those' stories," one longtime forum member wrote.
"I want to keep on reading about 'those' stories. KEEP posting," another responded.
Eventually, Wise Young, the CareCure forum administrator, weighed in with an all-too-common appraisal. "The sad thing is that the people who are doing this treatment don't seem to be assessing the patients in a rigorous way, documenting what they are doing and seeing in the patients, and [they are] keeping the procedure and the treatment secret," writes Young, a neuroscientist at Rutgers University in New Brunswick, New Jersey, who has visited...
Related Articles
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...